Chemotherapy-related agranulocytosis as a predictive factor for germline BRCA1 pathogenic variants in breast cancer patients: a retrospective cohort study
BACKGROUND: Carriers of germline pathogenic variants of the BRCA1 gene (gBRCA1) tend to have a higher incidence of haematological toxicity upon exposure to chemotherapy. We hypothesised that the occurrence of agranulocytosis during the first cycle of (neo-)adjuvant chemotherapy (C1) in breast cance...
Saved in:
| Main Authors: | Noémie Lang, Aurélie Ayme, Chang Ming, Jean‑Damien Combes, Victor N. Chappuis, Alex Friedlaender, Aurélie Vuilleumier, José L. Sandoval, Valeria Viassolo, Pierre O. Chappuis, S. Intidhar Labidi-Galy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2023-03-01
|
| Series: | Swiss Medical Weekly |
| Online Access: | https://smw.ch/index.php/smw/article/view/3307 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Screening of Germline BRCA1 and BRCA2 Variants in Nigerian Breast Cancer Patients
by: Abimbola F. Onyia MSc, et al.
Published: (2025-04-01) -
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
by: Tuya Pal, et al.
Published: (2024-11-01) -
BRCA1 promoter hypermethylation is not associated with germline variants in Polish breast cancer patients
by: Karolina Prajzendanc, et al.
Published: (2025-06-01) -
Characterization and functional analysis of BRCA1 and BRCA2 variants in a cohort of 100 unselected patients undergoing germline screening
by: Qianqian Shi, et al.
Published: (2025-09-01) -
Drug Agranulocytosis
by: A. V. Polunina, et al.
Published: (2010-12-01)